Wing-Kam Matthew Lam

• Reviewed European business unit (BU) s' submissions of monthly KPI & P&L, quarterly forecasts, 5-year plan, weekly sales reports and slide presentation to Group CFO
• Reviewed and analyzed 300+ financial models on lease renewals, capex projects/ tendered contracts and relevant assumptions to highlight underlying financial implications and risks to management
• Performed trend analyses and investigated actual vs budget/forecasted variances in monthly performance schedules with BU Finance Director and analysts to highlight underlying drivers of performance
• Prepared informative charts and slide presentation with raw Hyperion/ERP inputs to Group CFO on group-wide KPI's
• Ad hoc spreadsheet modelling with advanced formulas to aid in KPI review and the decision- making of the Group Investment Committee

Achievements

• Facilitated a breakeven EBIT for FY 22 with closures of loss making stores
• Maintained a trusted and cordial business partnership with various business functions

• Participated in 1 IPOs and 5 annual audits of listed clients in retail, trading, food, and hospitality industries
• Performed substantive analytical procedures and tests of details on P&L and balance sheet items, including AR/AP, inventory (NRV testing), revenue, gross profit, selling, and G&A expense items, etc.
• Performed ratio analyses and trend analyses on SAP and reports with Excel formulas, pivot tables, and VBA
• Analyzed the fluctuations and identified the patterns of the activity ratios
• Assisted in sensitivity analyses and monitored the impacts of different scenarios on cash flows

Achievements

• EXCEED Award in 2020 for exceptional client service in secondment to China
• Contributed to the listing of Shenzhen Hepalink Pharmaceutical Group Co., Ltd